Close

Search

Search Menu
Photonics Media Photonics Buyers' Guide Photonics EDU Photonics Spectra BioPhotonics EuroPhotonics Industrial Photonics Photonics Showcase Photonics ProdSpec Photonics Handbook
More News
share
Email Facebook Twitter Google+ LinkedIn Comments

Mauna Kea Sales Decline in 2015

BioPhotonics
Apr 2016
PARIS — Global medical device company Mauna Kea Technologies ended its 2015 fiscal year with a 22 percent decline from its 2014 sales.

"Following our announcement on October 8 of the company's intent to modify its commercialization strategy, we anticipated a dilution of sales productivity as the global leadership team and regional sales leaders worked to implement our new strategy,” said Sacha Loiseau, founder and CEO of Mauna Kea.

Sales in the Americas declined by 10 percent, with Mauna Kea citing the absence of sales in Brazil and its sluggish economy, compounded by a general slowdown of public funding. North American sales rose by 14 percent, while Asian-Pacific sales declined by 35 percent as a result of the delay in obtaining regulatory approval for the Cellvizio 100 microscopy system in China. Sales in Europe, the Middle East and Africa dropped 23 percent.

Mauna Kea Technologies is a global medical device company focused on endomicroscopy and tissue characterization.

BusinessEuropeFranceMauna KeaBiophotonicsendoscopyCellvizioearningsRapidScan

Comments
Terms & Conditions Privacy Policy About Us Contact Us
back to top
Facebook Twitter Instagram LinkedIn YouTube RSS
©2018 Photonics Media, 100 West St., Pittsfield, MA, 01201 USA, info@photonics.com

Photonics Media, Laurin Publishing
x Subscribe to BioPhotonics magazine - FREE!
We use cookies to improve user experience and analyze our website traffic as stated in our Privacy Policy. By using this website, you agree to the use of cookies unless you have disabled them.